{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T03:04:35Z","timestamp":1770519875914,"version":"3.49.0"},"reference-count":19,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,2,7]]},"DOI":"10.1248\/bpb.b25-00589","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:08:39Z","timestamp":1770415719000},"page":"273-280","source":"Crossref","is-referenced-by-count":0,"title":["C4ST-1 Overexpression Suppresses Osteoblast Differentiation &lt;i&gt;via&lt;\/i&gt; a Wnt\/&lt;i&gt;\u03b2&lt;\/i&gt;-Catenin-p53 Axis"],"prefix":"10.1248","volume":"49","author":[{"given":"Toshiyasu","family":"Koike","sequence":"first","affiliation":[{"name":"Laboratory of Biochemistry, Kobe Pharmaceutical University, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Nadanaka","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Kobe Pharmaceutical University, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Kobe Pharmaceutical University, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Daponte V, Henke K, Drissi H. Current perspectives on the multiple roles of osteoclasts: Mechanisms of osteoclast-osteoblast communication and potential clinical implications. <i>eLife<\/i>, <b>13<\/b>, e95083 (2024).","DOI":"10.7554\/eLife.95083"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Yamamoto M, Shibata Y, Ito Y, Fukui M, Kioka H, Shoji Y, Kitao T, Shirahase H, Hinoi E. Osteoblastgenic and osteogenic effects of KY-273 with CDK8\/19 inhibitory activity in bone marrow mesenchymal stem cells and female rats. <i>Biol. Pharm. Bull.<\/i>, <b>47<\/b>, 669\u2013679 (2024).","DOI":"10.1248\/bpb.b23-00834"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Arya PN, Saranya I, Selvamurugan N. Crosstalk between Wnt and bone morphogenetic protein signaling during osteogenic differentiation. <i>World J. Stem Cells<\/i>, <b>16<\/b>, 102\u2013113 (2024).","DOI":"10.4252\/wjsc.v16.i2.102"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Miyazaki T, Miyauchi S, Tawada A, Anada T, Matsuzaka S, Suzuki O. Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation. <i>J. Cell. Physiol.<\/i>, <b>217<\/b>, 769\u2013777 (2008).","DOI":"10.1002\/jcp.21557"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Nadanaka S, Ishida M, Ikegami M, Kitagawa H. Chondroitin 4-O-sulfotransferase-1 modulates Wnt-3a signaling through control of E disaccharide expression of chondroitin sulfate. <i>J. Biol. Chem.<\/i>, <b>283<\/b>, 27333\u201327343 (2008).","DOI":"10.1074\/jbc.M802997200"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ling L, Murali S, Stein GS, van Wijnen AJ, Cool SM. Glycosaminoglycans modulate RANKL-induced osteoclastogenesis. <i>J. Cell. Biochem.<\/i>, <b>109<\/b>, 1222\u20131231 (2010).","DOI":"10.1002\/jcb.22506"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Koike T, Mikami T, Tamura JI, Kitagawa H. Altered sulfation status of FAM20C-dependent chondroitin sulfate is associated with osteosclerotic bone dysplasia. <i>Nat. Commun.<\/i>, <b>13<\/b>, 7952 (2022).","DOI":"10.1038\/s41467-022-35687-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kl\u00fcppel M, Wight TN, Chan C, Hinek A, Wrana JL. Maintenance of chondroitin sulfation balance by chondroitin-4-sulfotransferase 1 is required for chondrocyte development and growth factor signaling during cartilage morphogenesis. <i>Development<\/i>, <b>132<\/b>, 3989\u20134003 (2005).","DOI":"10.1242\/dev.01948"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Uyama T, Ishida M, Izumikawa T, Trybala E, Tufaro F, Bergstrom T, Sugahara K, Kitagawa H. Chondroitin 4-O-sulfotransferase-1 regulates E disaccharide expression of chondroitin sulfate required for herpes simplex virus infectivity. <i>J. Biol. Chem.<\/i>, <b>281<\/b>, 38668\u201338674 (2006).","DOI":"10.1074\/jbc.M609320200"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Koike T, Izumikawa T, Tamura J, Kitagawa H. Chondroitin sulfate-E fine-tunes osteoblast differentiation <i>via<\/i> ERK1\/2, Smad3 and Smad1\/5\/8 signaling by binding to N-cadherin and cadherin-11. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>420<\/b>, 523\u2013529 (2012).","DOI":"10.1016\/j.bbrc.2012.03.024"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. <i>Science<\/i>, <b>285<\/b>, 1733\u20131737 (1999).","DOI":"10.1126\/science.285.5434.1733"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Yan X, Lv A, Xing Y, Liu B, Hou J, Huang W, Li Y. Inhibition of p53-p21 pathway promotes the differentiation of rat bone marrow mesenchymal stem cells into cardiomyocytes. <i>Mol. Cell. Biochem.<\/i>, <b>354<\/b>, 21\u201328 (2011).","DOI":"10.1007\/s11010-011-0801-x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Park CH, Chang JY, Hahm ER, Park S, Kim HK, Yang CH. Quercetin, a potent inhibitor against \u03b2-catenin\/Tcf signaling in SW480 colon cancer cells. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>328<\/b>, 227\u2013234 (2005).","DOI":"10.1016\/j.bbrc.2004.12.151"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Izumikawa T, Koike T, Shiozawa S, Sugahara K, Tamura J, Kitagawa H. Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization: chondroitin polymerization is achieved by multiple enzyme complexes consisting of chondroitin synthase family members. <i>J. Biol. Chem.<\/i>, <b>283<\/b>, 11396\u201311406 (2008).","DOI":"10.1074\/jbc.M707549200"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Miyata S, Komatsu Y, Yoshimura Y, Taya C, Kitagawa H. Persistent cortical plasticity by upregulation of chondroitin 6-sulfation. <i>Nat. Neurosci.<\/i>, <b>15<\/b>, 414\u2013422, S1\u2013S2 (2012).","DOI":"10.1038\/nn.3023"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S. <i>In vitro<\/i> differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. <i>J. Cell Biol.<\/i>, <b>96<\/b>, 191\u2013198 (1983).","DOI":"10.1083\/jcb.96.1.191"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Damalas A, Ben-Ze\u2019ev A, Simcha I, Shtutman M, Leal JF, Zhurinsky J, Geiger B, Oren M. Excess beta-catenin promotes accumulation of transcriptionally active p53. <i>EMBO J.<\/i>, <b>18<\/b>, 3054\u20133063 (1999).","DOI":"10.1093\/emboj\/18.11.3054"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Damalas A, Kahan S, Shtutman M, Ben-Ze\u2019ev A, Oren M. Deregulated \u03b2-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. <i>EMBO J.<\/i>, <b>20<\/b>, 4912\u20134922 (2001).","DOI":"10.1093\/emboj\/20.17.4912"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Wang X, Kua HY, Hu Y, Guo K, Zeng Q, Wu Q, Ng HH, Karsenty G, de Crombrugghe B, Yeh J, Li B. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. <i>J. Cell Biol.<\/i>, <b>172<\/b>, 115\u2013125 (2006).","DOI":"10.1083\/jcb.200507106"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/2\/49_b25-00589\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:31:47Z","timestamp":1770435107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/2\/49_b25-00589\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00589","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"article-number":"b25-00589"}}